Literature DB >> 18174030

An epidemic of dyssynchrony: but what does it mean?

David A Kass1.   

Abstract

Cardiac resynchronization therapy (CRT) is used to treat a subset of heart failure patients with discoordinate wall motion. Defining appropriate patients is important, and, although electrical delay (wide QRS) is commonly used, recent data show that measures of mechanical dyssynchrony improve the sensitivity and specificity of predicting responders (including patients with narrow QRS complexes). This has stimulated studies of dyssynchrony per se, and the phenomenon now appears to be very common in virtually all forms of heart failure. However, what all this dyssynchrony means clinically, and how or whether it should be treated by CRT or other means, remains unclear.

Entities:  

Mesh:

Year:  2008        PMID: 18174030     DOI: 10.1016/j.jacc.2007.09.027

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  38 in total

1.  Increasing knowledge and changing views in cardiac resynchronization therapy.

Authors:  Laszlo Buga; John G F Cleland
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 2.  Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; John E Sanderson; John Gorcsan
Journal:  Eur Heart J       Date:  2010-08-13       Impact factor: 29.983

3.  Measuring mechanical cardiac dyssynchrony in the 3-D era.

Authors:  Guido Germano; Serge D Van Kriekinge
Journal:  J Nucl Cardiol       Date:  2015-12-30       Impact factor: 5.952

4.  Maximum derivative of left ventricular pressure predicts cardiac mortality after cardiac resynchronization therapy.

Authors:  Hirohiko Suzuki; Masayuki Shimano; Yukihiko Yoshida; Yasuya Inden; Takashi Muramatsu; Yukiomi Tsuji; Naoya Tsuboi; Haruo Hirayama; Rei Shibata; Toyoaki Murohara
Journal:  Clin Cardiol       Date:  2010-12-08       Impact factor: 2.882

Review 5.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

6.  Left ventricular mechanical dyssynchrony assessment in long-standing type II diabetes mellitus patients with normal gated SPECT-MPI.

Authors:  Dharmender Malik; Bhagwant Mittal; Ashwani Sood; Madan Parmar; Gurvinder Kaur; Ajay Bahl
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

7.  Dyssynchronous ventricular activation in asymptomatic wolff-Parkinson-white syndrome: a risk factor for development of dilated cardiomyopathy.

Authors:  Floris Ea Udink Ten Cate; Nathalie Wiesner; Uwe Trieschmann; Markus Khalil; Narayanswami Sreeram
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

Review 8.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

9.  Prevalence and pathophysiologic attributes of ventricular dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Laurens F Tops; Kalpana Prakasa; Harikrishna Tandri; Darshan Dalal; Rahul Jain; Veronica L Dimaano; David Dombroski; Cynthia James; Crystal Tichnell; Amy Daly; Frank Marcus; Martin J Schalij; Jeroen J Bax; David Bluemke; Hugh Calkins; Theodore P Abraham
Journal:  J Am Coll Cardiol       Date:  2009-07-28       Impact factor: 24.094

10.  Radial dyssynchrony assessed by cardiovascular magnetic resonance in relation to left ventricular function, myocardial scarring and QRS duration in patients with heart failure.

Authors:  Paul W X Foley; Kayvan Khadjooi; Joseph A Ward; Russell E A Smith; Berthold Stegemann; Michael P Frenneaux; Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-24       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.